Streptococcal Toxic Shock Syndrome
To view the entire topic, please log in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
PATHOGENS
- Streptococcus pyogenes (Group A, GAS)
- S. pyogenes produces exotoxins SPEA, SPEB, and SPEC.
- These toxins are superantigens capable of activating up to 25% of T cells. Therapy selected to stop toxin production.
- S. pyogenes produces exotoxins SPEA, SPEB, and SPEC.
- Other Streptococcus species (described)
-- To view the remaining sections of this topic, please log in or purchase a subscription --
PATHOGENS
- Streptococcus pyogenes (Group A, GAS)
- S. pyogenes produces exotoxins SPEA, SPEB, and SPEC.
- These toxins are superantigens capable of activating up to 25% of T cells. Therapy selected to stop toxin production.
- S. pyogenes produces exotoxins SPEA, SPEB, and SPEC.
- Other Streptococcus species (described)
There's more to see -- the rest of this entry is available only to subscribers.